OPEN END TURBO OPTIONSSCHEIN SHORT - AMGEN | Real-time BOERSE MUENCHEN 05:55:11 31/05/2024 pm IST | ||
| 9.65 EUR | +0.73% |
|
| Current month | -24.03% | ||
| 1 month | -24.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 9.65 | +0.73% |
| 30/24/30 | 9.58 | -6.26% |
| 29/24/29 | 10.22 | +2.92% |
| 28/24/28 | 9.93 | +8.52% |
| 27/24/27 | 9.15 | -1.19% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 05:55 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GG2D29 |
| ISIN | DE000GG2D296 |
| Date issued | 10/01/2024 |
| Strike | 406.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.41 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.79 € |
|---|---|
| Lowest since issue | 7.88 € |
| Spread | 0.07 € |
| Spread % | 0.72% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
301
USD
Average target price
316.3
USD
Spread / Average Target
+5.07%
- Stock Market
- Certificates
- Certificat
